As of 2026-04-28, the Fair Value of Idera Pharmaceuticals Inc (IDRA) is -11.37 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.43 USD, the upside of Idera Pharmaceuticals Inc is -2,775.91%.
With the market price of 0.43 USD and our fair value calculation, Idera Pharmaceuticals Inc (IDRA) is not a good investment. Investing in IDRA stocks now will result in a potential loss of 2,775.91%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | 98.09 | -23.36 | - | - | 37.37 | |
| YoY growth | 187.07% | -123.81% | - | - | 31.63% | |
| Market Cap (mil) | 21.82 |
| P/E | |
| Forward P/E |
| EPS | -0.45 |
| Avg earnings growth rate | 31.63% |
| TTM earnings | -23.36 |